NOS3 and metabolic syndrome: The altered endothelial function induced by MetS was associated with a significant downregulation in the expression of the activated endothelial nitric oxide synthase in arterial tissue (p < 0.05; Figure 9D) and with a significant decrease (p < 0.05) in the release of nitric oxide (NO) that were prevented by the ingredients’ supplementation (Table 5).